Strategic Partnership Enhances Patient Engagement Platform with Advanced iCoreRx ePrescribing Software OCOEE, FL, Aug. 05, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ:ICCT) ("iCore" or the "Company"), a leading cloud-based software and technology company, today announced a new reseller agreement with mConsent, a leader in digital patient intake, patient communication and engagement solutions. Through this partnership, mConsent will now offer iCoreConnect's premier electronic prescribing software, iCo ...